Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Buy
1,661
+88
+6% +$18.9K ﹤0.01% 560
2026
Q1
$348K Buy
1,573
+76
+5% +$18.6K ﹤0.01% 534
2025
Q4
$380K Buy
+1,497
New +$376K ﹤0.01% 523

Other funds holding STE

TCW Group's STE Position: Q2 2026 in Review

TCW Group increased its Steris (STE) stake by 5.6% in Q2 2026, buying an estimated $18.9K and bringing the position to 1,661 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

TCW Group first reported a position in STE in Q4 2025 and has held it in 3 quarters since. The position peaked at $380K in Q4 2025. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • TCW Group held 1,661 shares of Steris worth $350K as of Q2 2026.
  • TCW Group bought 88 Steris shares in Q2 2026, an estimated $18.9K.
  • Steris made up ﹤0.01% of TCW Group's portfolio in Q2 2026, its #560 holding.
  • TCW Group first reported a position in Steris in Q4 2025 and has held it in 3 quarters since.
  • TCW Group's Steris position peaked at $380K in Q4 2025.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.